Event-free survival in patients with early HER2-positive breast cancer with a pathological complete response after HER2-targeted therapy: a pooled analysis - Swain, Sandra M.; Macharia, Harrison; Cortes, Javier; Dang, Chau; Gianni, Luca; Hurvitz, Sara A.; Jackisch, Christian; Schneeweiss, Andreas; Slamon, Dennis; Valagussa, Pinuccia; Du Toit, Yolande; Heinzmann, Dominik; et al. (Cancers, 2022)
Gesehen am 18.01.2023